Literature DB >> 8443798

The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells.

Y Saijo1, L Perlaky, B C Valdez, R K Busch, D Henning, W W Zhang, H Busch.   

Abstract

Malignant transformation of NIH3T3 cells was observed by transfection with the pSVX vector containing a sense human p120 cDNA construct (pSVX120). Subsequent transfection of these transformed cells with a dexamethasone inducible antisense p120 construct (pMSG021) markedly reduced the expression of human p120 and the growth rate of these transformed cells (Perklaky et al., Cancer Res., (1992) 52, 428-436). In the present study, a human breast cancer cell line (MCF-7) which expresses the p120 protein was transfected by electroporation with a pSVX plasmid-construct containing the antisense p120 cDNA (pSVX021). Clones containing the pSVX021 construct were selected and analyzed for expression of p120 mRNA, protein and growth characteristics. The expression of the p120 protein was inhibited by 44% in the antisense-transfected MCF-7pSVX021 cells; a 56% inhibition of cell-growth and a reduced colony formation in soft agarose were also observed. The growth of MCF-7 cells transfected with the p120 antisense construct was reduced by 93% in nude mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443798     DOI: 10.1016/0304-3835(93)90134-u

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.

Authors:  G L Prasad; R A Fuldner; H L Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

2.  Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene.

Authors:  J S Khillan; S W Li; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.

Authors:  Emma Yue Zhang; Massimo Cristofanilli; Fredika Robertson; James M Reuben; Zhaomei Mu; Ronald C Beavis; Hogune Im; Michael Snyder; Matan Hofree; Trey Ideker; Gilbert S Omenn; Susan Fanayan; Seul-Ki Jeong; Young-Ki Paik; Anna Fan Zhang; Shiaw-Lin Wu; William S Hancock
Journal:  J Proteome Res       Date:  2013-05-22       Impact factor: 4.466

4.  Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.

Authors:  H E Wheeler; E R Gamazon; A L Stark; P H O'Donnell; L K Gorsic; R S Huang; N J Cox; M E Dolan
Journal:  Pharmacogenomics J       Date:  2011-08-16       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.